150
Participants
Start Date
April 24, 2024
Primary Completion Date
October 31, 2025
Study Completion Date
October 31, 2026
IL-6
"Compare IL-6 level , as a marker of inflammation in all the 3 groups:~* POTS patients~* post-COVID-19 POTS~* gender, age, and BMI-matched controls, with history of COVID-19 infection without sequelae."
cytokines (IL-17, and IFN-ɣ)
"Compare Proinflammatory cells and its secreted cytokines (IL-17, and IFN-ɣ) in all the 3 groups:~* POTS patients~* post-COVID-19 POTS~* gender, age, and BMI-matched controls, with history of COVID-19 infection without sequelae"
Compass 31
Autonomic symptoms assessment questionnaire (COMPASS 31), in post-COVID-19 POTS and compare with POTS patients
RECRUITING
Cyndya Shibao, Nashville
American Heart Association
OTHER
Vanderbilt University Medical Center
OTHER